Cytokinetics CYTK
$50.78 −$0.68 (-1.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $52.48 +3.35%
Open$51.27
Prev close$51.46
Day range$50.60 – $53.45
Volume1.43M
Market cap$7.07B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts16
Average target$107.29+111.3% vs. price
- Buy 94%
- Hold 6%
Low $78.00Now $50.78Avg $107.29High $140.00
Recent rating changes
The last 20 actions on file set price targets from $78.00 to $140.00, averaging $109.00.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 9 Nov 2026 | H.C. Wainwright | BUY | $140.00 |
| 6 Nov 2026 | Truist Financial | BUY | $112.00 |
| 6 Nov 2026 | Citi | BUY | $105.00 |
| 5 Nov 2026 | Wells Fargo | BUY | $105.00 |
| 5 Nov 2026 | Piper Sandler | BUY | $107.00 |
| 5 Nov 2026 | Morgan Stanley | BUY | $103.00 |
| 5 Nov 2026 | Evercore | BUY | $100.00 |
| 5 Nov 2026 | Stifel | BUY | $108.00 |
| 5 Nov 2026 | Citi | BUY | $105.00 |
| 5 Nov 2026 | H.C. Wainwright | BUY | $140.00 |
| 5 Nov 2026 | Barclays | BUY | $110.00 |
| 4 Nov 2026 | BofA Securities | HOLD | $78.00 |
| 4 Nov 2026 | RBC Capital | BUY | $113.00 |
| 3 Nov 2026 | Morgan Stanley | BUY | $103.00 |
| 19 Oct 2026 | BofA Securities | HOLD | $81.00 |
| 19 Oct 2026 | H.C. Wainwright | BUY | $140.00 |
| 15 Oct 2026 | William Blair | BUY | – |
| 15 Oct 2026 | UBS | BUY | $104.00 |
| 14 Oct 2026 | UBS | BUY | $104.00 |
| 14 Oct 2026 | RBC Capital | BUY | $113.00 |
No comments yet — be the first to weigh in on CYTK.
Sign in to join the discussion.